No abstract available
Keywords:
CN-AML heterogeneity; NPM1 mutation; cytogenetically normal.
MeSH terms
-
Biomarkers, Tumor / genetics
-
Humans
-
Karyotype*
-
Leukemia, Myeloid, Acute / genetics*
-
Leukemia, Myeloid, Acute / mortality*
-
Leukemia, Myeloid, Acute / therapy
-
Mutation*
-
Nuclear Proteins / genetics*
-
Nucleophosmin
-
Patient Outcome Assessment
-
Prognosis
-
Recurrence
-
Treatment Outcome
Substances
-
Biomarkers, Tumor
-
NPM1 protein, human
-
Nuclear Proteins
-
Nucleophosmin